Get Started

Who We Are

The Lipid Association of India was born in 2012, with the aim of promoting the field of lipidology and spreading awareness among physicians, who treat patients with dyslipidemia, in order to help them face day to day challenges in treatment of dyslipidemia, which is a leading cause of morbidity and mortality in India.

Since its inception, LAI has conducted several regional conferences in India over the years, with the help of local experts to disseminate information on evidence-based management of dyslipidemia, also keeping in mind the challenging scenario in India. .......Read More

Sports is effective at lowering cholesterol

  • LAI promote healthy life style among the medical personal i.e. doctors.
  • LAI desires that you should screen your patients and fellow citizens for dyslipidemia and maitain their lipid levels as per LAI recommendations
  • LDL-Cholesterol levels should be maintained around 70 mg/dl irrespective of age
  • Please join our "National Awareness Campaign" of preventing all pre-mature cardiovascular diseases and deaths.

LAI Cricket Board Member

Dr. Raman Puri

Dr. Raman Puri

Chairman, LAI

Dr. Rashmi Nanda

President LAI Cricket Board

Dr Madhur Yadav

Vice President of LAI Cricket

Dr Vipul Gupta

Secretary LAI Cricket Board

Dr Shashi Kumar Singh

Captain LAI Cricket Team

Mr. Gyan

LAI Cricket Coordinator

Recent Events

2nd All India Healthy Heart Medicos Cricket Tournament 2019

This tournament date is 20th, 21st and 22nd (Friday, Saturday and Sunday) December 2019 at Delhi


Recommendations from expert consensus statement for management of dyslipidemia in Indian population by Lipid Association of India published on March 2016 in JAPI (Journal of The Association of Physicians of India)

Lipid Association of India (LAI) recommends screening of all adults for atherosclerotic cardiovascular disease risk factors especially lipid panel at age 20 or college entry. This should be done earlier if there is a family history of premature heart disease, dyslipidemia, obesity, or other risk factors.

LAI recommends LDL-C as primary target and Non HDL‐C as co‐primary treatment target.

Non-HDL-C comprises the cholesterol carried by all potentially atherogenic particles, including LDL, intermediate density lipoproteins, very low-density lipoproteins (VLDL) and VLDL remnants, chylomicron remnants, and lipoprotein (a).

Elevated TG is associated with increased risk of ASCVD, independent of LDL-C levels. Keep TG <150 mg/dL, preferably <100mg/dL.

The level of HDL-C is an important risk indicator and used in risk factor counting.

LAI recommends at least one fasting lipid profile though non-fasting lipid levels can be used in screening and in general risk estimation as per most international guidelines.

Risk Stratification for ASCVD (Atherosclerotic cardiovascular disease) by Lipid Association of India 2016

Risk Category
Very High risk
  • Established ASCVD
  • Diabetes with 2 major risk factors or evidence of end organ damage
  • Familial Homozygous Hypercholesterolemia
High Risk
  • 3 major ASCVD risk factors
  • Diabetes with 1 major risk factor or no evidence of end organ damage
  • CKD stage 3B or 4
  • LDL >190 mg/dl
  • Extreme of a single risk factor
  • Coronary Artery Calcium - CAC >300 AU
  • Lipoprotein a > 50mg/dl
  • Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors
Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors
  • Age ≥ 45 years in males and ≥ 55 years in females
  • Family history of premature ASCVD
  • Current Cigarette smoking or tobacco use
  • High blood pressure
  • Low HDL

Treatment goals and statin initiation thresholds according to ASCVD risk categories as per Lipid Association of India 2016

Risk Category Treatment Goal Consider Drug Therapy
  LDL-C (mg/dl) Non HDL-C (mg/dl) LDL-C (mg/dl) Non HDL-C (mg/dl)
Very High Risk < 50 < 80 >=50 >=80
High Risk < 70 < 100 >=70 >=100
Moderate Risk < 100 < 130 >=100 >=130
Low Risk < 100 < 130 >=130* >=160
* In low risk group, consider therapy after an initial adequate non-pharmacological intervention for 3 months

Frequently Asked Questions

Star of the Match

Man of the Series : Dr Vikram Dutta
Bowler of the Series : Dr Mahesh Shekoba
Batsman of the Series : Dr Davin Omanakuttan
Fielder of the Series : Dr Suman Kumar Banik
LAI XI vs Club X

Match Result

Winners Team Hyderabad

2nd All India Healthy Heart Medicos Cricket Tournament 2019

Runner up – Team LAI

2nd All India Healthy Heart Medicos Cricket Tournament 2019

Winners Team LAI

1st All India Healthy Heart Medicos Cricket Tournament 2018

Runner up – Team Hyderabad

1st All India Healthy Heart Medicos Cricket Tournament 2018

LAI Cricket Team

Dr. Shashi Kumar

All Rounder, Captain

Dr Vipul Gupta


Dr. Anand

All Rounder

Dr. Aditya

All Rounder

Dr. Bhupender

All Rounder

Dr. Deepak

All Rounder

Dr. Rakesh

All Rounder

Dr. Pankaj

Wicketkeeper, Vice Captain

Dr. Rajeeb

All Rounder

Dr. Sameer

All Rounder

Dr. Siddharth

All Rounder

Dr. Siddharth Narula

All Rounder

Dr. Vivek

All Rounder

Our Team Captains

Dr. Shashi Kumar

Captain, LAI Team

Dr. Foys Ullah

Captain, Bangladesh Team

Dr Mir Mahir Ali

Captain, Bengaluru Team

Dr Sunil Kakodkar

Captain, Goa Team


Captain, Hyderabad Team

Dr Milind Gangurde

Captain, Nasik IMA Team

Dr Ambesh Panwar

Captain, Meerut Team

Dr Amit Bhootra

Captain, Amritsar Team


If you also want to share your thought about LAI Click Here


Lipid Association of India (LAI) is a team of eminent doctors in the field of Cardiovascular Medicine, Internal Medicine, Pharmacology and young doctors who are interested in the field of lipidology.

A -26, 2nd Floor, South Extension Part 2, New Delhi
Pincode 110049, India



Your message has been sent. Thank you!